Vascular Biology and Human Diseases: From Molecular Pathways to Novel Therapeutics
joint with Uncomplicating Diabetes: Reducing the Burden of Diabetes-Related End-Organ Injury
Organizer(s): Elisabetta Dejana, Anne C. Eichmann and Gavin O. ThurstonDate: February 25 - March 01, 2018
Location: Eldorado Hotel & Spa, Santa Fe, NM, USA
Recent years have seen rapid progress in our knowledge of how the vascular system is formed during embryo development and in adults expressing in proliferative diseases such as cancer. It has become unequivocally evident that endothelial cells express highly specific and distinct functions in arteries, veins and lymphatics. Moreover, endothelial cells are able to further modify their functional properties in order to meet the specific needs of the different organs. This conference will address the mechanisms that orchestrate organ-specific endothelial differentiation, making a connection between endothelial dysfunction and organ pathology. The major challenge will be to link our experimental knowledge to the understanding of human vascular diseases. The symposium will bring together teams of vascular biologists, neuroscientists, immunologists and clinicians from all over the world to share their recent discoveries and to direct future efforts to find novel and more precise therapies.
Scholarship Deadline: November 16 2017
Discounted Abstract Deadline: November 16 2017
Abstract Deadline: November 28 2017
Discounted Registration Deadline: December 20 2017
We gratefully acknowledge the generous grant for this conference provided by:National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1 R13 HL140903-01
Funding for this conference was made possible (in part) by 1 R13 HL140903-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.